PPI analysis in transcriptomics reveals that celastrol, an intervention in RA, downregulates key targets associated with inflammation and immune regulation, such as TNF, CXCR4, SPI1, PTGS2, ASCL1, IRF4, and CCL3. Here, CXCR4 is linked to rheumatoid arthritis.